Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma

Fig. 1

Nomogram developed to predict the overall survival of PDAC patients. A Nomogram developed by integrating metabolic syndrome and clinical pathological parameters for predicting 6-month and 1-, 2-year survival of PDAC patients; (B–D). Calibration curve for risk of 6-month and 1-, 2-year survival of metabolic syndrome

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us